Provided by Tiger Trade Technology Pte. Ltd.

Maison Solutions

1.63
+0.150010.14%
Post-market: 1.58-0.0500-3.07%17:34 EDT
Volume:39.15M
Turnover:76.18M
Market Cap:1.39M
PE:-0.06
High:2.27
Open:2.05
Low:1.57
Close:1.48
52wk High:198.00
52wk Low:1.24
Shares:855.30K
Float Shares:558.80K
Volume Ratio:3.31
T/O Rate:7006.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-26.7021
EPS(LYR):3.35
ROE:-127.03%
ROA:-7.62%
PB:0.18
PE(LYR):0.49

Loading ...

Maison Solutions Says All Outstanding Convertible Notes are Paid Off

Reuters
·
Yesterday

CSPC Pharma's SYS6090 (JMT108) Receives FDA Fast Track Designation for MSS/pMMR Metastatic Colorectal Cancer Treatment

Stock News
·
Yesterday

Maison Solutions Receives NASDAQ Notice over Late Annual Filing, Risks Noncompliance with Listing Rules

Reuters
·
Yesterday

Maison Solutions faces Nasdaq compliance filing challenge

TIPRANKS
·
Yesterday

Major Investor Makes Bold Move in Maison Solutions Inc. Class A Stock

TIPRANKS
·
Aug 22

HRT Financial LP Sells 32,556 Maison Solutions Shares for $59,903.04

Reuters
·
Aug 21

Adagene to Participate in Three Upcoming Investor Conferences

GlobeNewswire
·
Aug 20

HRT Financial Disposes of 154,394 Maison Solutions Shares Worth $219,239.48

Reuters
·
Aug 19

Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer

GlobeNewswire
·
Aug 18

HRT Financial LP Reports $42,582 Maison Solutions Common Share Purchase

Reuters
·
Aug 15

Maison Solutions Inc Expected to Post a Loss of 87 Cents a Share - Earnings Preview

Reuters
·
Aug 13

HRT Financial LP Disposes of 4,329 Maison Solutions Common Shares for $6,103.89

Reuters
·
Aug 13

Maison Solutions Initial Beneficial Ownership Filing Shows HRT Financial LP Stake of 100,843 Shares

Reuters
·
Aug 13

PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101

GlobeNewswire
·
Aug 11

Press Release: Agenus Reports Second Quarter 2026 Results and Advances Phase 3 Robbin Trial of Bot+bal in Neoadjuvant MSS Colon Cancer

Dow Jones
·
Aug 06

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

GlobeNewswire
·
Aug 03

Maison Solutions Delays Annual Report Filing as Audit Work Continues

Reuters
·
Jul 30

NASDAQ Trade Halt Volatility Trading Pause at 10:15 Am

Reuters
·
Jul 29

Maison Solutions CEO says valuation ‘does not fully reflect’ long-term potential

TIPRANKS
·
Jul 29

Maison Solutions Agrees to Sell San Gabriel, Monrovia Store Assets for $4.5 Million

Reuters
·
Jul 29